Effects of a physical activity and endometriosis-based education program delivered by videoconference on endometriosis symptoms: the CRESCENDO program (inCRease physical Exercise and Sport to Combat ENDOmetriosis) protocol study.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 17 08 2023
accepted: 09 11 2023
medline: 29 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Endometriosis is a chronic disease characterized by growth of endometrial tissue outside the uterine cavity which could affect 200 million women (The term "woman" is used for convenience. Individuals gendered as man or as nonbinary can also suffer from this disease) worldwide. One of the most common symptoms of endometriosis is pelvic chronic pain associated with fatigue. This pain can cause psychological distress and interpersonal difficulties. As for several chronic diseases, adapted physical activity could help to manage the physical and psychological symptoms. The present study will investigate the effects of a videoconference-based adapted physical activity combined with endometriosis-based education program on quality of life, pain, fatigue, and other psychological symptoms and on physical activity. This multicentric randomized-controlled trial will propose to 200 patients with endometriosis to be part of a trial which includes a 6-month program with 45 min to more than 120 min a week of adapted physical activity and/or 12 sessions of endometriosis-based education program. Effects of the program will be compared to a control group in which patients will be placed on a waiting list. All participants will be followed up 3 and 6 months after the intervention. None of the participants will be blind to the allocated trial arm. The primary outcome measure will be quality of life. Secondary outcomes will include endometriosis-related perceived pain, fatigue, physical activity, and also self-image, stereotypes, motivational variables, perceived support, kinesiophobia, basic psychological need related to physical activity, and physical activity barriers. General linear models and multilevel models will be performed. Predictor, moderator, and mediator variables will be investigated. This study is one of the first trials to test the effects of a combined adapted physical activity and education program for improving endometriosis symptoms and physical activity. The results will help to improve care for patients with endometriosis. ClinicalTrials.gov, NCT05831735 . Date of registration: April 25, 2023.

Sections du résumé

BACKGROUND BACKGROUND
Endometriosis is a chronic disease characterized by growth of endometrial tissue outside the uterine cavity which could affect 200 million women (The term "woman" is used for convenience. Individuals gendered as man or as nonbinary can also suffer from this disease) worldwide. One of the most common symptoms of endometriosis is pelvic chronic pain associated with fatigue. This pain can cause psychological distress and interpersonal difficulties. As for several chronic diseases, adapted physical activity could help to manage the physical and psychological symptoms. The present study will investigate the effects of a videoconference-based adapted physical activity combined with endometriosis-based education program on quality of life, pain, fatigue, and other psychological symptoms and on physical activity.
METHODS METHODS
This multicentric randomized-controlled trial will propose to 200 patients with endometriosis to be part of a trial which includes a 6-month program with 45 min to more than 120 min a week of adapted physical activity and/or 12 sessions of endometriosis-based education program. Effects of the program will be compared to a control group in which patients will be placed on a waiting list. All participants will be followed up 3 and 6 months after the intervention. None of the participants will be blind to the allocated trial arm. The primary outcome measure will be quality of life. Secondary outcomes will include endometriosis-related perceived pain, fatigue, physical activity, and also self-image, stereotypes, motivational variables, perceived support, kinesiophobia, basic psychological need related to physical activity, and physical activity barriers. General linear models and multilevel models will be performed. Predictor, moderator, and mediator variables will be investigated.
DISCUSSION CONCLUSIONS
This study is one of the first trials to test the effects of a combined adapted physical activity and education program for improving endometriosis symptoms and physical activity. The results will help to improve care for patients with endometriosis.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov, NCT05831735 . Date of registration: April 25, 2023.

Identifiants

pubmed: 38012776
doi: 10.1186/s13063-023-07792-1
pii: 10.1186/s13063-023-07792-1
pmc: PMC10680283
doi:

Banques de données

ClinicalTrials.gov
['NCT05831735']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

759

Informations de copyright

© 2023. The Author(s).

Références

Prev Chronic Dis. 2021 Apr 08;18:E33
pubmed: 33830913
J Gynecol Obstet Hum Reprod. 2017 Mar;46(3):235-242
pubmed: 28403920
Nat Rev Dis Primers. 2018 Jul 19;4(1):9
pubmed: 30026507
J Manag Care Spec Pharm. 2017 Jul;23(7):745-754
pubmed: 28650252
Front Reprod Health. 2021;3:
pubmed: 36284640
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Hum Reprod. 2012 May;27(5):1292-9
pubmed: 22422778
Pain. 2011 Oct;152(10):2399-2404
pubmed: 21856077
Int J Environ Res Public Health. 2023 Jan 17;20(3):
pubmed: 36767032
Pain. 2011 Apr;152(4):717-725
pubmed: 21168972
Reprod Sci. 2020 Jul;27(7):1423-1435
pubmed: 32318984
Biomed Res Int. 2016;2016:3260952
pubmed: 27148550
Prev Med. 1987 Nov;16(6):825-36
pubmed: 3432232
BMJ Open. 2021 Aug 9;11(8):e046603
pubmed: 34373298
J Psychosom Res. 2020 Aug 6;137:110213
pubmed: 32781264
J Health Psychol. 2019 Mar;24(3):386-396
pubmed: 27872385
Int J Behav Nutr Phys Act. 2013 Dec 07;10:135
pubmed: 24313992
Int J Environ Res Public Health. 2022 Feb 02;19(3):
pubmed: 35162761
BMC Neurol. 2020 Mar 13;20(1):93
pubmed: 32169035
Eur J Vasc Endovasc Surg. 2017 Jul;54(1):58-68
pubmed: 28528678
Health Psychol Rev. 2021 Jun;15(2):214-244
pubmed: 31983293
BJOG. 2019 Nov;126(12):1414-1416
pubmed: 31359584
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1822-1829
pubmed: 34235718
Health Psychol. 2015 Oct;34(10):1022-32
pubmed: 25642840
Hum Reprod. 2017 Jul 1;32(7):1432-1438
pubmed: 28482063
Hum Reprod. 2016 Apr;31(4):712-22
pubmed: 26851604
J Telemed Telecare. 2023 Oct;29(9):716-724
pubmed: 34137641
Cochrane Database Syst Rev. 2017 Jan 14;1:CD011279
pubmed: 28087891
Reprod Sci. 2019 Jun;26(6):785-793
pubmed: 30231769
Int J Gynaecol Obstet. 2014 Feb;124(2):169-73
pubmed: 24290537
BMC Womens Health. 2021 Oct 9;21(1):355
pubmed: 34627209
Int J Gynaecol Obstet. 1995 Jun;49(3):299-304
pubmed: 9764869
Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:1-15
pubmed: 30017581
Crit Rev Oncol Hematol. 2018 Feb;122:52-59
pubmed: 29458789
Disabil Health J. 2015 Oct;8(4):547-56
pubmed: 26087721
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Facts Views Vis Obgyn. 2020 Oct 08;12(3):197-205
pubmed: 33123695
Acta Obstet Gynecol Scand. 2021 Sep;100(9):1595-1601
pubmed: 33999412
J Psychosoc Oncol. 2014;32(6):708-26
pubmed: 25174265
Am J Prev Med. 2002 May;22(4 Suppl):73-107
pubmed: 11985936
Int J Environ Res Public Health. 2020 May 21;17(10):
pubmed: 32455821
J Phys Act Health. 2014 May;11(4):790-800
pubmed: 25078523
Psychol Health Med. 2012;17(6):685-97
pubmed: 22409699
J Affect Disord. 2016 Jan 15;190:282-285
pubmed: 26544610
Reprod Biol Endocrinol. 2014 Jan 06;12:4
pubmed: 24393293

Auteurs

Géraldine Escriva-Boulley (G)

Université de Haute-Alsace, Université de Strasbourg, Université de Lorraine, LISEC UR 2310, F-68100, Mulhouse, France. geraldine.escriva-boulley@uha.fr.

Charles-André Philip (CA)

Clinique gynécologique et obstétricale, Hôpital de la Croix-Rousse, groupe hospitalier Nord, CHU de Lyon-HCL, 103, grande rue de la Croix-Rousse, 69317, Lyon cedex, France.

Sophie Warembourg (S)

Clinique gynécologique et obstétricale, Hôpital de la Croix-Rousse, groupe hospitalier Nord, CHU de Lyon-HCL, 103, grande rue de la Croix-Rousse, 69317, Lyon cedex, France.

Lionel Lenotre (L)

Faculté des Sciences et Techniques, Université de Haute-Alsace, 18 Rue des Frères Lumière, 68200, Mulhouse, France.
PASTA - Processus aléatoires spatio-temporels et leurs applications, Inria Nancy - Grand Est, Villers-lès-, Nancy, France.

Patrice Flore (P)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Patrice Faure (P)

Grenoble University Hospital, Avenue Maquis du Grésivaudan, 38700, La Tronche, France.

Thierry Michy (T)

Department of Gynecology, Grenoble University Hospital, Avenue Maquis du Grésivaudan, 38700, La Tronche, France.

Vincent Letouzey (V)

Service de Gynécologie Obstétrique, Nîmes, France.

Carole Arnold (C)

Université de Lorraine, Inserm, UMRS 1256, NGERE - Nutrition, Genetics, and Environmental Risk Exposure, F-54000, Nancy, France.

Claire Piluso (C)

Université de Haute-Alsace, Université de Strasbourg, SAGE, F-68100, Mulhouse, France.

Loic Chalmel (L)

Université de Haute-Alsace, Université de Strasbourg, Université de Lorraine, LISEC UR 2310, F-68100, Mulhouse, France.

Ramzi Kacem (R)

Service gynécologie GHRMSA, Hôpital Emile Muller, Mulhouse, France.

Georges Fabrice Blum (GF)

Cabinet Médical, Clinique du Diaconat-Fonderie et Université de Haute-Alsace, Mulhouse, France.

Renaud Detayrac (R)

Service de Gynécologie Obstétrique, Nîmes, France.

Candice Trocmé (C)

Grenoble University Hospital, Avenue Maquis du Grésivaudan, 38700, La Tronche, France.

Isabelle Brigaud (I)

Université de Haute-Alsace, CNRS, IS2M UMR 7361, Mulhouse, France.

Ulysse Herbach (U)

Université de Lorraine, CNRS, Inria, IECL, F-54000, Nancy, France.

Patricia Branche (P)

Service d'Anesthésie Réanimation Chirurgicale, Hospices Civils de Lyon, Groupement Hospitalier Nord Hôpital de la Croix-Rousse, 103 Grande Rue de la Croix-Rousse, F-69317, Lyon, France.

Emilie Faller (E)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, 67200, Strasbourg, France.

Aïna Chalabaev (A)

Univ. Grenoble Alpes, SENS, 38000, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH